{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:29:39Z","timestamp":1760056179532,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Johnson Cancer Center of Kansas State University"},{"DOI":"10.13039\/100007829","name":"Kansas State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jpba.2017.12.058","type":"journal-article","created":{"date-parts":[[2017,12,30]],"date-time":"2017-12-30T11:53:10Z","timestamp":1514634790000},"page":"106-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Inhibition of UDP-glucose dehydrogenase by 6-thiopurine and its oxidative metabolites: Possible mechanism for its interaction within the bilirubin excretion pathway and 6TP associated liver toxicity"],"prefix":"10.1016","volume":"151","author":[{"given":"Chamitha J.","family":"Weeramange","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassie M.","family":"Binns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J.","family":"Rafferty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpba.2017.12.058_bib0005","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jama.301.4.452","article-title":"Acute lymphoblastic leukemia","volume":"301","author":"Torpy","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jpba.2017.12.058_bib0010","first-page":"1967","article-title":"Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil","volume":"41","author":"Tsuruo","year":"1981","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jpba.2017.12.058_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003088-198815010-00002","article-title":"Clinical pharmacokinetics of doxorubicin","volume":"15","author":"Speth","year":"1988","journal-title":"Clin. Pharmacokinet."},{"issue":"10","key":"10.1016\/j.jpba.2017.12.058_bib0020","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0959-8049(98)00228-7","article-title":"Etoposide: four decades of development of a topoisomerase II inhibitor","volume":"34","author":"Hande","year":"1998","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.jpba.2017.12.058_bib0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nut.2015.06.010","article-title":"\u03c9-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: a randomized placebo-controlled study","volume":"32","author":"Elbarbary","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.jpba.2017.12.058_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2015.12.002","article-title":"Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in children","volume":"83","author":"Tiphaine","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jpba.2017.12.058_bib0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2125.2008.03248.x","article-title":"Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine","volume":"66","author":"Hawwa","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2017.12.058_bib0040","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3324\/haematol.2016.153312","article-title":"Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome","volume":"102","author":"Yuan","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jpba.2017.12.058_bib0045","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc2292","article-title":"Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer","volume":"8","author":"Karran","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.jpba.2017.12.058_bib0050","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/004982599238434","article-title":"In vitro metabolism of 6-mercaptopurine by human liver cytosol","volume":"29","author":"Rowland","year":"1999","journal-title":"Xenobiotica"},{"issue":"15","key":"10.1016\/j.jpba.2017.12.058_bib0055","first-page":"5810","article-title":"Differing contribution of thiopurine methyltransferase to mercaptopurine: thioguanine effects in human leukemic cells","volume":"61","author":"Dervieux","year":"2001","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.jpba.2017.12.058_bib0060","first-page":"2872","article-title":"Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine","volume":"35","author":"Nelson","year":"1975","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jpba.2017.12.058_bib0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2125.2007.02985.x","article-title":"IMPDH activity in thiopurine-treated patients with inflammatory bowel disease \u2013relation to TPMT activity and metabolite concentrations","volume":"65","author":"Haglund","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.jpba.2017.12.058_bib0070","first-page":"738","article-title":"A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine","volume":"34","author":"Tidd","year":"1974","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jpba.2017.12.058_bib0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13073-015-0150-6","article-title":"Molecular insight into thiopurine resistance: transcriptomic signature in lymphoblastoid cell lines","volume":"7","author":"Chouchana","year":"2015","journal-title":"Genome Med."},{"issue":"4","key":"10.1016\/j.jpba.2017.12.058_bib0080","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1182\/blood-2002-02-0495","article-title":"De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination with methotrexate in vivo","volume":"100","author":"Dervieux","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jpba.2017.12.058_bib0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI118767","article-title":"Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine","volume":"98","author":"Carethers","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jpba.2017.12.058_bib0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"9","key":"10.1016\/j.jpba.2017.12.058_bib0095","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jama.1964.03060350028007","article-title":"Hepatotoxicity of mercaptopurine","volume":"188","author":"Einhorn","year":"1964","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jpba.2017.12.058_bib0100","first-page":"299","article-title":"Jaundice in the adult patient","volume":"69","author":"Roche","year":"2004","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.jpba.2017.12.058_bib0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpba.2014.01.025","article-title":"Simultaneous determination of bilirubin and its glucuronides in liver microsomes and recombinant UGT1A1 enzyme incubation systems by HPLC method and its application to bilirubin glucuronidation studies","volume":"92","author":"Ma","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11","key":"10.1016\/j.jpba.2017.12.058_bib0110","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1124\/dmd.105.005447","article-title":"In vitro inhibition of UDP glucuronosyltransferase by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation","volume":"33","author":"Zhang","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.jpba.2017.12.058_bib0115","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/dmd.110.035030","article-title":"Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates\/inhibitors","volume":"39","author":"Zhou","year":"2011","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.jpba.2017.12.058_bib0120","doi-asserted-by":"crossref","first-page":"e0155218","DOI":"10.1371\/journal.pone.0155218","article-title":"The impact of azathioprine-associated lymphopenia on the onset of opportunistic infections in patients with inflammatory bowel disease","volume":"11","author":"V\u00f6gelin","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jpba.2017.12.058_bib0125","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/jop.12274","article-title":"A practical guide to the use of thiopurines in oral medicine","volume":"44","author":"Hullah","year":"2015","journal-title":"J. Oral Pathol. Med."},{"issue":"4","key":"10.1016\/j.jpba.2017.12.058_bib0130","first-page":"264","article-title":"A novel liquid chromatography tandem mass spectrometry method for the estimation of bilirubin glucuronides and its application to in vitro enzyme assays","volume":"10","author":"Siva","year":"2016","journal-title":"Drug Metab. Lett."},{"issue":"1","key":"10.1016\/j.jpba.2017.12.058_bib0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1021\/acs.biochem.6b01044","article-title":"Allostery and hysteresis are coupled in human UDP-glucose dehydrogenase","volume":"56","author":"Beattie","year":"2017","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.jpba.2017.12.058_bib0140","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/toxsci\/kfv144","article-title":"Uridine diphosphate-glucuronosyltransferase (UGT) xenobiotic metabolizing activity and genetic evolution in pinniped species","volume":"147","author":"Kakehi","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.jpba.2017.12.058_bib0145","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1021\/ol060208a","article-title":"Thionation using Fluorous Lawesson's reagent","volume":"8","author":"Kaleta","year":"2006","journal-title":"Org. Lett."},{"issue":"10","key":"10.1016\/j.jpba.2017.12.058_bib0150","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/jo01104a014","article-title":"Potential purine antagonists. XIII. Synthesis of some 8-methylpurines1","volume":"23","author":"Koppel","year":"1958","journal-title":"J. Organ. Chem."},{"key":"10.1016\/j.jpba.2017.12.058_bib0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bioelechem.2012.03.002","article-title":"In situ regeneration of NADH via lipoamide dehydrogenase-catalyzed electron transfer reaction evidenced by spectroelectrochemistry","volume":"86","author":"Tam","year":"2012","journal-title":"Bioelectrochem. (Amsterdam, Netherlands)"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517325025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517325025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:53:13Z","timestamp":1759999993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517325025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":31,"alternative-id":["S0731708517325025"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.12.058","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of UDP-glucose dehydrogenase by 6-thiopurine and its oxidative metabolites: Possible mechanism for its interaction within the bilirubin excretion pathway and 6TP associated liver toxicity","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.12.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}